Canadian Cardiovascular Society (CCS) guidance on COVID-19 and concerns regarding use of cardiovascular medications, including ACEi/ARB/ARNi, low-dose ASA and non-steroidal anti-inflammatory drugs (NSAIDS)

Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Collection: 
COVID-19 Resources to Support Clinical Care
Type of Resource: 
Guideline
Country: 
Canada
For: 
Healthcare Professionals
Source: 
Government (Canada)